Study Designed to Assess the Safety, Tolerability and PK of PTI-808 in Healthy Volunteers and in Adults With Cystic Fibrosis
Clinical trial NCT03251092 · COMPLETED
Trial details
- NCT number
- NCT03251092
- Sponsor
- Proteostasis Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-17
- Primary completion
- 2019-12-23
- Enrollment
- 179
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.